An Analysis of Peripheral Blood T Cell Subsets on Rheumatoid Arthritis

PHASE2CompletedINTERVENTIONAL
Enrollment

10

Participants

Timeline

Start Date

July 31, 2006

Primary Completion Date

May 31, 2008

Study Completion Date

May 31, 2008

Conditions
Rheumatoid Arthritis
Interventions
DRUG

rituximab

Patients are taking stable dose of methotrexate and at least 10mg folic acid per week for at least 4 weeks. Rituximab is administrated as 1000mg intravenous infusion on day 1 and day 15. Premedication as standard prescription consists of methylprednisolone 100mg IV, Chlorpheniramine maleate(piriton 10mg IV and oral paracetamol 500mg to be given 30 minutes before each infusion of rituximab. Oral prednisolone 60mg is tob e given from day 1-6 after rituximab infusion and 30mg from day 7-13.

Trial Locations (1)

Unknown

Department of Medicine and Therapeutics, Hong Kong

All Listed Sponsors
lead

Chinese University of Hong Kong

OTHER

NCT00555542 - An Analysis of Peripheral Blood T Cell Subsets on Rheumatoid Arthritis | Biotech Hunter | Biotech Hunter